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Background/Purpose: The aim of our study is to develop a concise and effective dementia screening tool
for use in primary care, wherein we selected ﬁve items from the Global Deterioration Scale (GDS) that
were most predictive of dementia diagnosis.
Methods: Our study population comprised 191 patients older than 60 years who visited four university
hospitals between 2008 and 2011 for impaired memory or medical care. Our 5-item screening tool is an
abbreviated version of the GDS. We compared the assessment results obtained through our model with
those obtained through the GDS in order to evaluate the accuracy of our tool in detecting dementia.
Results: The screening tool had a sensitivity of 91.2%, speciﬁcity of 75.0%, a cutoff value of 12.495, and an
area under the curve of 0.911 (95% conﬁdence interval, 0.862e0.948; p < 0.05).
Conclusion: We anticipate that our abridged GDS, composed of ﬁve items, will facilitate a rapid, yet
effective assessment of patients in primary care centers. Its use will beneﬁt both patients and medical
professionals by minimizing the length of time required to conduct the assessment, and by allowing early
diagnosis and care of patients. However, further research with a larger population is required to verify its
efﬁcacy.
Copyright © 2015, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
The prevalence of dementia differs among regions: in Western
countries, 3.6e10.3% of people 65 years of age have dementia1,2;
in Japan, 5.8e6.7% of people 65 years of age3,4 suffer from de-
mentia; and in Korea, 6.8e9.0% of people 65 years of age suffer
from dementia. The prevalence of dementia is expected to increase
to 15.1% by 2050 and to double every 20 years.5e8 The most well-
known rating scales that measure dementia severity are the
Global Deterioration Scale (GDS), the Clinical Dementia Rating
(CDR), the Mini Mental Status Examination (MMSE), and the Min-
imum Data Set.9e13 These tools are widely used as criteria for
measuring dementia severity in clinical research and evaluating thedicine, Kyung Hee University
, Seoul 130-872, South Korea.
n).
inical Gerontology & Geriatrics. Pub
d/4.0/).efﬁcacy of dementia drugs in clinical testing.14 The GDS and CDR
evaluate various areas such as cognition, function, and behavioral
symptoms. The GDS and CDR are covered under the National Health
Insurance for prescription drugs for dementia.15 The GDS has the
advantage of being easy to use. The CDR has the disadvantage of
taking at least 30 minutes for clinicians to administer.16 The GDS
classiﬁes dementia into seven stages, whereas the CDR classiﬁes
dementia into ﬁve stages. The GDS also has advantages over the
CDR because it is more detailed and can be used to evaluate sub-
jective cognitive impairment.17,18 Therefore, the GDS is a more
important tool for evaluating cognitive function, and it has the
advantage of easy administration. However, its scoring is not sys-
tematic and may be inaccurate; thus, it is not appropriate for use in
primarymedical care.14 The GDS is believed to be useful inmaking a
quick and accurate diagnosis of dementia if used as a screening test
in the form of an abridged version consisting of speciﬁc items for a
systematic diagnosis. For an early diagnosis of dementia, checkinglished by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
Table 1
General characteristics of the study participants.
Characteristics N (%)
Sex
Male 65 (34.03)
Female 126 (65.97)
Residential area
Large city 111 (58.12)
Small city 52 (27.23)
Town 28 (14.66)
Marital status
Married 116 (60.73)
Widowed 1 (0.52)
Bereaved 74 (38.74)
Education
Uneducated 33 (17.28)
Primary schoolehigh school 125 (65.4)
University 33 (17.28)
Cohabit
Yes 117 (61.26)
No 74 (38.74)
Religion
Buddhism 46 (24.08)
Catholicism 20 (10.47)
Christianity 68 (35.6)
None/rest 57 (29.85)
Caregiver(informant)
Spouse 62 (32.46)
Children 97 (50.79)
Sibling/friend/employed nurse 32 (16.75)
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and caregivers voluntarily report symptoms of a decline in cogni-
tive function.15
In a previous study, Won et al19 selected 182 patients 50 years
of age who had memory impairment and completed a cognitive
test from the neurology or neuropsychiatry department in four
university hospitals. An algorithm of the GDS stage was made and
reported in the study. However, the study was limited in that only
seven (3.8%) participants had normal cognitive function, which
corresponded to 1 point on the GDS. In the study, the accurate
prediction of GDS stage ranging from 1 to 7 points was reported as
difﬁcult.19
This study aims to present an abridged version of the GDS,
which easily and quickly distinguishes the dementia groups from
the normal groups.
2. Methods
2.1. Materials
Compared with Won et al's19 study, in this study, 30 elderly
people who visited the department of family medicine in one
university hospital and 60 elderly people who took a cognitive test
at the neurology departments in two university hospitals were
added to the existing participants. A total of 272 people met the
criteria mentioned above. However, those with hearing, vision, or
speech impairments, who visited without a caregiver, or who had
important missing values, were excluded from the study. The study
for ﬁnal analysis included a total of 191 participants. The past
study19 included people older than 50 years and with some cases
that had missing variables, but in this study, the study population
included participants whowere older than 60 years and those cases
with missing variables by systematic principle were excluded. As a
result, the selection bias due to the exclusion of 81 patients, which
is about one-third of the total study samples, was low. The survey
was conducted with the company of the patients' caregivers,
deﬁned as spouses, relatives, or acquaintances, who spent time
with the patient at least once a week.
2.2. Methods
After consultation and a consensus meeting with ﬁve dementia
specialists, 31 sample items were extracted from all stages of the
GDS (GDS 1eGDS 31), and with the 31 items, the questionnaire was
formed (Appendix 1). Each item on the questionnaire was based on
GDS, which was shown to be valid and reliable.9,14,17,20 The ques-
tionnaire included 20 survey questions for the caregivers and 11
items that were evaluated by a tester and addressed accordingly.
The psychometrician rated the participants with a GDS stage not by
a newly publishedmethod, whichwas described byWon et al,19 but
by the original staging method. The GDS has seven stages (1e7),
which follows the suggestion of Reisberg et al9: those who were
classiﬁed as stage 1 (normal) to stage 3 [mild cognitive impairment
(MCI)] comprised the normal group, whereas those who were
classiﬁed as stage 4 (mild dementia) to stage 7 (severe dementia)
comprised the dementia group. The authors named the operational
dementia as GDS-based dementia.
2.3. Statistical analysis
The odds ratio was obtained using logistic regression analysis,
and the weight was found by multiplying each odds ratio by each
variable. The Dementia Screening Score was obtained by summing
up the total scores from these items.The relationship between each question of GDS items and GDS-
based dementia (GDS stage  4) was analyzed by chi-square test.
Receiver operating characteristic curve was used to choose a single
cut-point at the point of maximized sensitivity and speciﬁcity. All
statistical analyses were carried out with PASW version 18.0 for
Windows (SPSS Inc., Chicago, IL, USA).
2.4. Ethics statement
This study was approved by the Institutional Review Board of
Kyung Hee University Hospital, in Seoul, South Korea (approval ID:
KMCIRB 1436-03). Informed consent was conﬁrmed by the board.
3. Results
The total study populationwas 191, comprising 65 men and 126
women, with an average age of 74.4 years. Approximately 60% of
patients were married or living with cohabitants, of whom 17%
were undereducated (Table 1). The distribution of GDS were rep-
resented, including 17 (8.9%) patients with GDS Stage 1 (no
cognitive decline), 19 (10.0%) patients with GDS Stage 2 (age-
associated memory impairment), 64 (33.5%) patients with GDS
Stage 3 (MCI), 49 (25.7%) patients with GDS Stage 4 (mild demen-
tia), 27 (14.1%) patients with GDS Stage 5 (moderate dementia), and
15 (7.9%) patients with GDS Stage 6 (moderately severe dementia).
There were no patients with GDS Stage 7 (severe dementia;
Table 2).
The multivariate logistic regression analysis with forward
stepwise method was used to predict GDS-based dementia: GDS
Stage 20 (got lost traveling to an unfamiliar location) was most
signiﬁcant, followed by GDS Stage 30 (orientation to time), GDS
Stage 8 (decreased performance in employment), and GDS Stage 25
(counting back from 100 in 7's). Finally, adding GDS 31 (orientation
to place) resulted in p ¼ 0.027. When more items were included in
the model, the p value increased to >0.05. As a result, only ﬁve
items, which are highly predictive of dementia, were selected
(Table 3). The response options of these ﬁve questions were
Table 2
Distribution of actual GDS stages in the study participants.
GDS stage N (%)
1 (No cognitive decline) 17 (8.9)
2 (Age associated memory impairment) 19 (10.0)
3 (Mild cognitive impairment) 64 (33.5)
4 (Mild dementia) 49 (25.7)
5 (Moderate dementia) 27 (14.1)
6 (Moderately severe dementia) 15 (7.9)
7 (Severe dementia) 0 (0.0)
GDS ¼ Global Deterioration Scale, 1e7 point rating instrument.
Table 3
Predictors of dementia by multivariate logistic regression analysis with forward
stepwise method.
Step Items p
1 GDS Stage 20a <0.0001
2 GDS Stage 30b <0.0001
3 GDS Stage 8c 0.0006
4 GDS Stage 25d 0.0015
5 GDS Stage 31e 0.0277
GDS ¼ Global Deterioration Scale, 1e7 point rating instrument.
a GDS Stage 20, Get lost traveling to an unfamiliar location.
b GDS Stage 30, Orientation to time (date, day of week, season).
c GDS Stage 8, Diminished ability at fulﬁlling responsibilities at work or in other
social settings.
d GDS Stage 25, Competence in consecutive calculations (100-7).
e GDS Stage 31, Orientation to place (present place).
Table 4
Dichotomized categorization of the GDS.
Question Original response option Dichotomized response option
GDS Stage 8a 1 No
2 Yes
GDS Stage 20b 1 No
2, 3, 4 Yes
GDS Stage 25c 0 All correct
1, 2, 3, 4, 5 At least 1 incorrect
GDS Stage 30d 1 All correct
2, 3 At least 1 incorrect
GDS Stage 31e 1 Correct
2 Incorrect
GDS ¼ Global Deterioration Scale, 1e7 point rating instrument.
a GDS Stage 8, Diminished ability at fulﬁlling responsibilities at work or in other
social settings.
b GDS Stage 20, Get lost traveling to an unfamiliar location.
c GDS Stage 25, Competence in consecutive calculations (100-7).
d GDS Stage 30, Orientation to time (date, day of week, season).
e GDS Stage 31, Orientation to place (present place).
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tions for the answer. The frequency showed the percentage of
detecting dementia was suggested, and according to the frequency,
the response options of the questions were dichotomized based on
the point where the percentage of dementia shows maximal
differences.
The response options of the questions in GDS 20 (got lost trav-
eling to an unfamiliar location), GDS 25 (counting back from 100 in
7's), GDS 30 (orientation to time) was dichotomized into two cat-
egories based on the frequency of differentiating dementia to the
normal population. For example, there were three response options
in GDS Stage 30, and it was dichotomized into Options 1e3. This
was attributable to GDS-based dementia being predicted highly in
patients who choose response Options 2 or 3. If the responder's
reply for GDS 20 was that he or she never got lost in unfamiliar
places, the answer optionwould be “no”, and if he or she got lost at
least once, the answer would be “yes”. In other words, for GDS 25,
counting back from 100 in 7's (100-7), the response options were
divided into “all correct” and “at least one incorrect” (Table 4). If the
responder calculated ﬁve times accurately, he or she would score 1
point, and if not, the score would be 3.815 (Table 5).
Dichotomized response options for the ﬁve items are described
in Figure 1 and Table 5. GDS-based dementia was highly suspected
when the patient marked option 2 in GDS Stage 8; Options 2e4 in
GDS Stage 20; Options 1e5 in GDS Stage 25; Options 2 and 3 in GDS
Stage 30; and Option 2 in GDS Stage 31 (Table 4). After applying the
multivariate logistic regression model, the adjusted odds ratio of
the ﬁve items are stated in Table 5, and the weight was set by
multiplying each odds ratio by each variable to formulate the De-
mentia Screening Score. If all ﬁve items were resolved, the total
score would be 5 points. If the responder answered to all ﬁve
questions incorrectly, the score would be 23.304.
The receiver operating characteristic curve of the Dementia
Screening Score for dementia diagnosis was created in which the
area under the curve was 0.911 [95% conﬁdence interval (CI),
0.862e0.948], and its best cutoff value was 12.495. The screeningtool had a sensitivity of 91.2%, speciﬁcity of 75.0%, with a cutoff
value of 12.495, and its area under the curve was 0.911 (95% CI,
0.862e0.948; Figure 2).4. Discussion
Early diagnosis of dementia is critical for effectively managing
patients so that they can receive early treatment after diagnosis,
and thereby delay the progression of disease and minimize loss of
function. The existing neuropsychological test is time-consuming
and is potentially unpleasant for patients; also, medical staff
members at primary healthcare centers are generally not familiar
with the test.22,23 Therefore, a simpliﬁed screening tool is needed.
At GDS Stage 4, cognition impairment occurs and maintaining a
normal life becomes difﬁcult for patients.24 As cognition impair-
ment progresses, psychiatric morbidity signiﬁcantly increases be-
tween GDS Stages 3 and 4, and functional impairment falls into 51%
at GDS Stage 4.21 Hence, it appears to be important to distinguish
between Stage 3 and Stage 4.
A similar study used the CDR scale as a screening tool in
detecting MCI and dementia in patients.25 In this study, the ﬁve
items that were most predictive of a dementia diagnosis were
selected from the CDR. All possible combinations of four out of
these ﬁve items were used to create ﬁve separate 4-item prediction
rules. The model with maximized sensitivity and speciﬁcity at a
single cut-point was selected and tested to distinguish MCI and
dementia from the normal group. This model yielded a sensitivity
of 95% (95% CI, 92e97%) and a speciﬁcity of 91% (95% CI 86e95%). It
also diagnosed MCI and dementia as a bundle. In our study, MCI
patients are distinguished from those who exhibit clear symptoms
of dementia.
Kalbe et al26 developed a 3-minute Rapid Dementia Screening
Test composed of two tasks that distinguish between the normal
group and the dementia group. One of the tasks involved stating
items that could be purchased in the supermarket, and the other
number transcoding in Arabic numbers, had to be converted into
number words, and the number words to do the opposite. Their
screening tool proved to be highly reliable, with sensitivity and
speciﬁcity that were higher than those of the MMSE, at 72% and
89%, respectively.26 Although it separated dementia patients from
the normal group with high reliability, the study's sample size was
small, consisting of only 201 patients. Moreover, the tool fell short
of making deﬁnitive diagnoses of dementia.
Our study engaged a diverse group of patients from four de-
mentia clinics and one family medicine clinic in university
Table 5
Independent predictors of dementia by logistic regression analysis.
Question Univariate model Multivariate model
Odds ratio (95% CI) Odds ratio (95% CI)
GDS 8a Yes 8.602 (4.285e17.27) 5.561 (2.24e13.806)
No 1 1
GDS 20b Yes 11.193 (5.646e22.19) 4.433 (1.882e10.44)
No 1 1
GDS 25c At least 1 incorrect 8.078 (3.658e17.84) 3.815 (1.358e10.72)
All correct 1 1
GDS 30d At least 1 incorrect 12.179 (5.928e25.02) 3.711 (1.493e9.23)
All correct 1 1
GDS 31e Incorrect 13.623 (5.056e36.70) 5.784 (1.75e19.12)
Correct 1 1
CI ¼ conﬁdence interval; GDS ¼ Global Deterioration Scale, 1e7 point rating instrument.
a GDS Stage 8, Diminished ability at fulﬁlling responsibilities at work or in other social settings.
b GDS Stage 20, Get lost traveling to an unfamiliar location.
c GDS Stage 25, Competence in consecutive calculations (100-7).
d GDS Stage 30, Orientation to time (date, day of week, season).
e GDS Stage 31, Orientation to place (present place).
Figure 1. Frequency (%)* to detect dementia for each question (GDS item).
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based dementia group from the normal group, and achieved a
sensitivity of 91.2% and a speciﬁcity of 75%. In addition, the tool may
allow for rapid and efﬁcient diagnosis in primary care. Therefore,
our tool can help delay the progression of dementia by allowing
early diagnosis of the disease, which in turn allows for timely care
and intervention.Figure 2. Receiver operating characteristic (ROC) curve for Dementia Screening Score
to predict dementia.Our study, however, has certain limitations. Patients with GDS
Stage 7 were not included in this study, and the number of patients
with GDS Stage 1 was fairly small. Such limitations call for further
research that represents these two patient groups. Additionally,
although our tool proved helpful in detecting GDS-based dementia,
the size of our sample was small. Therefore, conducting additional
tests on larger samples, including primary care centers, will be
beneﬁcial in conﬁrming the tool's accuracy. Additionally, this study
has limitation in that we did not compare our results with the re-
sults of the MMSE or the CDR, as GDS is not the gold standard in
diagnosing dementia. Lastly, although we did distinguish the de-
mentia group from the normal group, we did not distinguish the
MCI group from the normal group.
In conclusion, we developed a 5-question screening tool, which
proved to be just as effective as a 31-question screening tool in
detecting MCI and GDS-based dementia. Hence, we think that the
tool can be effectively used in primary care centers, but further
veriﬁcation is needed.Conﬂicts of interest
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